Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients

NCT05147051 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Acidosis

Interventions

DRUG: Meglumine Sodium Succinate
DRUG: Placebo

Sponsor

POLYSAN Scientific & Technological Pharmaceutical Company

Collaborators

[object Object]